AMPH Max Pain
The max pain for Amphastar Pharmaceuticals Inc (AMPH) options expiring Nov 20, 2026 (6 DTE) is $22.50.
AMPH Max Pain by Expiry
The Max Pain for all expiration dates of AMPH.
| Expiration | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Nov 20, 2026 6 DTE monthly | 22.50 | -6.50 (-22.41%) |
| Dec 18, 2026 34 DTE monthly | 20.00 | -9.00 (-31.03%) |
| Mar 19, 2027 125 DTE monthly | 25.00 | -4.00 (-13.79%) |
| Jun 17, 2027 215 DTE weekly | 30.00 | 1.00 (3.45%) |
AMPH Max Pain FAQ
What is max pain?
Max pain is the price where the total value of all open calls and puts would be lowest at expiration, so option buyers as a group would lose the most. Some traders watch it as a level the stock may drift toward near expiration, because option sellers, often market makers, hedge their positions in ways that can pull the price toward heavily traded strikes. It is a theory, not a guarantee.
What is AMPH max pain this week?
As of the Nov 13, 2026 close, max pain for Amphastar Pharmaceuticals options expiring Nov 20, 2026 is $22.50. The chart above shows the exact max pain for each expiration date.
Does AMPH trade above or below its max pain?
Amphastar Pharmaceuticals closed above its near-term max pain on 20 of the last 20 trading days. On Nov 13, 2026 it closed at $29.37, 30.5% above max pain of $22.50.
How has AMPH max pain changed recently?
Over the last 20 trading days, near-term max pain for Amphastar Pharmaceuticals ranged from $22.25 to $23.10. It went from $23.10 on Oct 19, 2026 to $22.50 on Nov 13, 2026. See the AMPH max pain history for a longer view.
What is Amphastar Pharmaceuticals Inc?
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products.